CirQPOD Shoulder Study

NCT ID: NCT04299776

Last Updated: 2022-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-28

Study Completion Date

2020-03-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intrathoracic pressure regulation (IPR) therapy, delivered by impedance threshold devices (ITDs) or intrathoracic pressure regulators (ITPRs), increases venous return, preload, cardiac output, blood pressure, and cerebral perfusion pressure by intermittently creating negative intrathoracic pressure, which improves circulation in hypotensive animals and humans. By increasing systemic pressure and cerebral perfusion as well as promoting venous return, IPR therapy potentially improves cerebral oxygenation. The lower intrathoracic pressures may also reduce pulmonary artery pressure, although there is currently little evidence one way or the other. Use of an ITPR can counteract the multifactorial intraoperative hypotension common during surgeries under general anesthesia, and reduce the need for other measures to treat such hypotension; however, they might simultaneously promote pulmonary complications.

The investigators will therefore assess whether the use of intrathoracic pressure regulation in adults having shoulder surgery under general anesthesia in the sitting position reduces vasoactive medication requirements compared with routine clinical practice. Simultaneously, the investigators will assess the effect of intrathoracic pressure regulation on pulmonary circulation, cerebral oxygenation, and postoperative atelectasis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypotension on Induction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IPR therapy

Intrathoracic pressure regulation (IPR) therapy level of -10 cmH2O (-7 cmH2O for run-in) provided by the CirQPOD device during shoulder surgery in the sitting position

Group Type EXPERIMENTAL

CirQPOD

Intervention Type DEVICE

CirQPOD is connected between the wye piece on ventilator/anesthesia machine tubing and the patient's airway and generates negative intrathoracic pressure during the expiratory phase of ventilation which has been shown to improve blood flow.

Standard airway

Standard airway pressure (PEEP of +5 cmH2O) during shoulder surgery in the sitting position

Group Type ACTIVE_COMPARATOR

Standard airway management

Intervention Type DEVICE

Standard airway management during surgery (PEEP of +5 cmH2O)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CirQPOD

CirQPOD is connected between the wye piece on ventilator/anesthesia machine tubing and the patient's airway and generates negative intrathoracic pressure during the expiratory phase of ventilation which has been shown to improve blood flow.

Intervention Type DEVICE

Standard airway management

Standard airway management during surgery (PEEP of +5 cmH2O)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years
* American Society of Anesthesiologists (ASA) physical status class ≤3
* Scheduled for surgery in sitting/ beach-chair positions under general anesthesia in the Cleveland Clinic main campus
* Planned length of surgery \>60 minutes

Exclusion Criteria

* Severe peripheral vascular disease or other contraindication for use of vasopressor infusion
* Obstructive lung disease - moderate or severe asthma or COPD
* Baseline hypoxemia (SpO2\<92% on room air)
* Body Mass Index (BMI) \>35
* Congestive heart failure
* Pneumothorax or hemothorax
* Uncontrolled hemorrhage
* Planned intraoperative hypotension
* Contraindication to trans-esophageal echocardiography (esophageal stricture, surgery involving the esophagus or stomach)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Cleveland Clinic

OTHER

Sponsor Role collaborator

Zoll Medical Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Outcomes Research, Anesthesia Institute, Cleveland Clinic

Cleveland, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

40701

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Non-invasive Fluid Management
NCT02892799 UNKNOWN NA
The Intensive Care Platform Trial
NCT06667999 RECRUITING PHASE4
Fluids in Sepsis and Septic Shock
NCT02748382 COMPLETED PHASE2/PHASE3